Filters close
Released: 19-Jul-2023 12:05 PM EDT
Collection of Articles Reports Advances in Building Cellular Organization Maps of the Human Body
Pittsburgh Supercomputing Center

A set of nine scientific papers was released today in the Nature family of journals and the journal Cell Reports describing breakthroughs in creating an open framework for scientists to map the individual cells of the human body in two and three dimensions.

   
Newswise: A new milestone for flexible magnetic sensors
Released: 18-Jul-2023 6:05 PM EDT
A new milestone for flexible magnetic sensors
Bar-Ilan University

A group of researchers from Bar-Ilan University and Ben Gurion University has reported a giant leap of more than an order of magnitude improvement in the sensitivity of flexible magneto-resistive sensors.

Newswise: Safe train transport
Released: 18-Jul-2023 4:00 PM EDT
Safe train transport
Oak Ridge National Laboratory

Oak Ridge National Laboratory researchers used images from a photo-sharing website to identify crude oil train routes across the nation to provide data that could help transportation planners better understand regional impacts.

Not for public release

This news release is embargoed until 17-Jul-2023 5:00 PM EDT Released to reporters: 11-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 10-Jul-2023 5:00 PM EDT Released to reporters: 5-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 10-Jul-2023 5:00 PM EDT Released to reporters: 5-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 10-Jul-2023 5:00 PM EDT Released to reporters: 5-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 26-Jun-2023 5:00 PM EDT Released to reporters: 20-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 26-Jun-2023 5:00 PM EDT Released to reporters: 20-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 23-Jun-2023 12:55 PM EDT
BP Below 120 Could Be Target to Prevent Common Heart Condition
University of California, San Francisco (UCSF)

UCSF researchers have found that aggressive blood pressure control can lower the risk of left ventricular conduction disease, a common heart condition that often leads to pacemaker implantation.

Newswise: Novel way to manipulate exotic materials
Released: 20-Jun-2023 2:05 PM EDT
Novel way to manipulate exotic materials
Oak Ridge National Laboratory

An advance in a topological insulator material — whose interior behaves like an electrical insulator but whose surface behaves like a conductor — could revolutionize the fields of next-generation electronics and quantum computing, according to scientists at Oak Ridge National Laboratory.

Released: 20-Jun-2023 10:05 AM EDT
Wistar Institute Study Gives New Insight into How Cancer Metastasizes to the Brain 
Wistar Institute

PHILADELPHIA — (June 20, 2023) — When cancer that starts in the body metastasizes to the brain, it is almost always lethal, in part because so few treatment options exist. Now a new study by Wistar scientists published in Nature Communications shows that a type of brain cell called astrocytes plays an important role in promoting brain metastasis by recruiting a specific subpopulation of immune cells.



close
1.7954